Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

TOP: Recombinant Human Parathyroid Hormone (ALX1-11) on Fracture Incidence in Women With Postmenopausal Osteoporosis

This study has been completed.
Information provided by:
Shire Identifier:
First received: September 9, 2005
Last updated: November 10, 2015
Last verified: September 2005
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2003
  Primary Completion Date: November 2003 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):